Micro and Nanocarrier-Based Delivery Systems for Active Compounds
This special issue belongs to the section "Pharmaceutical Technology".
Special Issue Information
Dear Colleagues,
Drug delivery systems based on micro- and nanocarriers have emerged as promising strategies to improve the stability, bioavailability, and therapeutic efficacy of active compounds in the pharmaceutical field. These systems allow for the protection and delivery of bioactive molecules, potentially reducing adverse events and modulating the drug release profile. Furthermore, they can increase the solubility and bioavailability of poorly soluble compounds, as well as promote greater permeability through different biological barriers. This special edition aims to bring together original studies and reviews related to the development, characterization, and application of micro- and nanostructured systems for the delivery of active compounds. Studies involving polymeric and lipid nanoparticles, hybrid systems, liposomes, nanoemulsions, micro- and nanogels, micelles, microcapsules, microparticles, and other innovative controlled-release approaches are welcome. It is expected that this special edition will contribute to expanding scientific knowledge and promoting new translational perspectives in the area of drug delivery and advanced pharmaceutical formulations.
Dr. Douglas Dourado
Dr. Éverton do Nascimento Alencar
Dr. Fabio Rocha Formiga
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems
- lipid nanoparticles
- polymeric nanoparticles
- liposomes
- micro/nanoemulsions
- micro/nanogels
- microparticles
- microcapsules
- bioavailability
- pharmaceutical formulations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

